Polymer Capital Management HK LTD Acquires New Position in SPDR S&P Biotech ETF $XBI

Polymer Capital Management HK LTD bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 105,300 shares of the exchange traded fund’s stock, valued at approximately $16,664,000. SPDR S&P Biotech ETF makes up 0.8% of Polymer Capital Management HK LTD’s holdings, making the stock its 15th largest position. Polymer Capital Management HK LTD owned about 0.16% of SPDR S&P Biotech ETF at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. Wealth Management Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $547,000. Keystone Investors PTE Ltd. acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $12,022,000. Jessup Wealth Management Inc acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $1,053,000. Lalia Capital LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $12,193,000. Finally, Rockefeller Capital Management L.P. lifted its position in shares of SPDR S&P Biotech ETF by 44.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 236,057 shares of the exchange traded fund’s stock valued at $28,782,000 after acquiring an additional 72,636 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $165.73 on Monday. The stock has a market cap of $10.82 billion, a P/E ratio of 11.47 and a beta of 0.83. The stock’s 50 day simple moving average is $153.99 and its 200 day simple moving average is $137.76. SPDR S&P Biotech ETF has a 1-year low of $88.60 and a 1-year high of $169.68.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.